9/28/2021I-Mab's Chinese IND Accepted for P2 Trial of Enoblituzumab in Combo wi...

9/28/2021Genelux and Newsoara Announce License Deal for Oncolytic Immunotherapi...

9/28/2021China's "Hatch-Waxman" System: A Comparative Overview

9/27/2021CDE Solicits Public Comments on Draft of the Technical Guidelines for ...

9/27/2021CDE Solicits Public Comments on Draft of the Technical Guidelines for ...

9/27/2021JW Therapeutics Granted Chinese IND Approval for Multiple Myeloma CAR ...

9/27/2021Bio-Thera and Intract Pharma Enter License Pact for Soteria and Phlora...

9/27/2021Innovent and UNION Therapeutics Enter License Deal for Next-generation...

9/27/2021Beijing Wantai to Initiate Trial for Nasal Spray COVID-19 Vaccine Cand...

9/27/2021Neurophth Completes GMP Manufacturing Facility for Gene Therapy Produ...

9/27/2021Transcenta Cleared for Chinese IND of Anti-sclerostin mAb TST002

9/24/2021Everest Medicines Announces IND Approval of Class 1 Anti-infective SPR...

9/24/2021Akeso's Chinese NDA for Cadonilimab Accepted by NMPA

9/24/2021Healthcare Units of Chinese IT Giants Under Pressure As State Media C...

9/24/2021Review of Performance Results of Listed Chinese Pharma Companies H1/20...

9/24/2021Review of R&D Investments of Selected Listed Chinese Pharma Companies ...

9/24/2021Snapshot of BMI System Financial Performance in H1/2021

9/24/2021Recent Executive Moves

9/23/2021Sihuan/Xuanzhu and SignalChem Announce Licensing Deal for SLC-391 in G...

9/23/2021Guangzhou Pharma Eyes Public Listing of Subsidiaries

9/23/2021Cytiva Triples Bioprocessing Single-Use Consumables Capacity in China

9/23/2021Scopus Granted Chinese Patent for CpG-STAT3 Inhibitor DUET-02

9/23/2021Innovent's sNDA for Sintilimab in Combo with Chemotherapy as First-L...

9/23/2021Prevalence of Depressive Disorders and Treatment in China: A Cross-Sec...

9/22/2021NMPA Issues Q2/2021 Drug Regulatory Statistics Report

9/22/2021China-based CMS Joins BaseLaunch as Latest Partner

9/20/2021Leading Chinese Pharma Players Move on the Korean Market

9/20/2021CDE Solicits Public Comments on Draft of the Technical Guidelines for ...

9/20/2021CNIPA Issues Interpretation of Administrative Adjudication of Patent L...

9/19/2021WiCON Publishes the China Pharmaceutical Guide 2021 (16th Edition)

Page:195/801 Total number of articles:24022: [First][<<] [193] [194] [195] [196] [197] [>>] [End]